Anti-Amyloid Drugs for Alzheimer's Disease: Considering the Role of Depression

This article examines how anti-amyloid monoclonal antibodies used to treat Alzheimer's disease may interact with or influence depression, a common comorbidity in elderly patients. The review discusses the neurobiological connections between amyloid pathology and mood disorders, and implications for treatment outcomes.